Global Methicillin-Susceptible Staphylococcus Aureus Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Cephalosporins
  • 1.2.3 Vancomycin
  • 1.2.4 Linezolid
  • 1.2.5 Others
• 1.3 Market by Application
  • 1.3.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Perspective (2016-2027)
• 2.2 Methicillin-Susceptible Staphylococcus Aureus Growth Trends by Regions
  • 2.2.1 Methicillin-Susceptible Staphylococcus Aureus Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Methicillin-Susceptible Staphylococcus Aureus Historic Market Share by Regions (2016-2021)
  • 2.2.3 Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Regions (2022-2027)
• 2.3 Methicillin-Susceptible Staphylococcus Aureus Industry Dynamic
  • 2.3.1 Methicillin-Susceptible Staphylococcus Aureus Market Trends
  • 2.3.2 Methicillin-Susceptible Staphylococcus Aureus Market Drivers
  • 2.3.3 Methicillin-Susceptible Staphylococcus Aureus Market Challenges
  • 2.3.4 Methicillin-Susceptible Staphylococcus Aureus Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Methicillin-Susceptible Staphylococcus Aureus Players by Revenue
  • 3.1.1 Global Top Methicillin-Susceptible Staphylococcus Aureus Players by Revenue (2016-2021)
  • 3.1.2 Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Players (2016-2021)
• 3.2 Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Methicillin-Susceptible Staphylococcus Aureus Revenue
• 3.4 Global Methicillin-Susceptible Staphylococcus Aureus Market Concentration Ratio
  • 3.4.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Methicillin-Susceptible Staphylococcus Aureus Revenue in 2020
• 3.5 Methicillin-Susceptible Staphylococcus Aureus Key Players Head office and Area Served
• 3.6 Key Players Methicillin-Susceptible Staphylococcus Aureus Product Solution and Service
• 3.7 Date of Enter into Methicillin-Susceptible Staphylococcus Aureus Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Methicillin-Susceptible Staphylococcus Aureus Breakdown Data by Type

• 4.1 Global Methicillin-Susceptible Staphylococcus Aureus Historic Market Size by Type (2016-2021)
• 4.2 Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Type (2022-2027)

5 Methicillin-Susceptible Staphylococcus Aureus Breakdown Data by Application

• 5.1 Global Methicillin-Susceptible Staphylococcus Aureus Historic Market Size by Application (2016-2021)
• 5.2 Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
• 6.2 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type
  • 6.2.1 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2021)
  • 6.2.2 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2022-2027)
  • 6.2.3 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2027)
• 6.3 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application
  • 6.3.1 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2021)
  • 6.3.2 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2022-2027)
  • 6.3.3 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2027)
• 6.4 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country
  • 6.4.1 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021)
  • 6.4.2 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
• 7.2 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Type
  • 7.2.1 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2021)
  • 7.2.2 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2022-2027)
  • 7.2.3 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2027)
• 7.3 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Application
  • 7.3.1 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2021)
  • 7.3.2 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2022-2027)
  • 7.3.3 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2027)
• 7.4 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country
  • 7.4.1 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021)
  • 7.4.2 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
• 8.2 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Type
  • 8.2.1 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Application
  • 8.3.1 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region
  • 8.4.1 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
• 9.2 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type
  • 9.2.1 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2021)
  • 9.2.2 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2022-2027)
  • 9.2.3 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2027)
• 9.3 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application
  • 9.3.1 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2021)
  • 9.3.2 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2022-2027)
  • 9.3.3 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2027)
• 9.4 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country
  • 9.4.1 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021)
  • 9.4.2 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
• 10.2 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Type
  • 10.2.1 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Application
  • 10.3.1 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country
  • 10.4.1 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Dainippon Sumitomo Pharma Co., Ltd
  • 11.1.1 Dainippon Sumitomo Pharma Co., Ltd Company Details
  • 11.1.2 Dainippon Sumitomo Pharma Co., Ltd Business Overview
  • 11.1.3 Dainippon Sumitomo Pharma Co., Ltd Methicillin-Susceptible Staphylococcus Aureus Introduction
  • 11.1.4 Dainippon Sumitomo Pharma Co., Ltd Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
  • 11.1.5 Dainippon Sumitomo Pharma Co., Ltd Recent Development
• 11.2 Immtech Pharmaceuticals, Inc.
  • 11.2.1 Immtech Pharmaceuticals, Inc. Company Details
  • 11.2.2 Immtech Pharmaceuticals, Inc. Business Overview
  • 11.2.3 Immtech Pharmaceuticals, Inc. Methicillin-Susceptible Staphylococcus Aureus Introduction
  • 11.2.4 Immtech Pharmaceuticals, Inc. Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
  • 11.2.5 Immtech Pharmaceuticals, Inc. Recent Development
• 11.3 Lytix Biopharma AS
  • 11.3.1 Lytix Biopharma AS Company Details
  • 11.3.2 Lytix Biopharma AS Business Overview
  • 11.3.3 Lytix Biopharma AS Methicillin-Susceptible Staphylococcus Aureus Introduction
  • 11.3.4 Lytix Biopharma AS Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
  • 11.3.5 Lytix Biopharma AS Recent Development
• 11.4 PharmaIN Corporation
  • 11.4.1 PharmaIN Corporation Company Details
  • 11.4.2 PharmaIN Corporation Business Overview
  • 11.4.3 PharmaIN Corporation Methicillin-Susceptible Staphylococcus Aureus Introduction
  • 11.4.4 PharmaIN Corporation Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
  • 11.4.5 PharmaIN Corporation Recent Development
• 11.5 Cubist Pharmaceuticals
  • 11.5.1 Cubist Pharmaceuticals Company Details
  • 11.5.2 Cubist Pharmaceuticals Business Overview
  • 11.5.3 Cubist Pharmaceuticals Methicillin-Susceptible Staphylococcus Aureus Introduction
  • 11.5.4 Cubist Pharmaceuticals Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
  • 11.5.5 Cubist Pharmaceuticals Recent Development
• 11.6 Kenta Biotech AG
  • 11.6.1 Kenta Biotech AG Company Details
  • 11.6.2 Kenta Biotech AG Business Overview
  • 11.6.3 Kenta Biotech AG Methicillin-Susceptible Staphylococcus Aureus Introduction
  • 11.6.4 Kenta Biotech AG Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
  • 11.6.5 Kenta Biotech AG Recent Development
• 11.7 Arsanis Biosciences GmbH
  • 11.7.1 Arsanis Biosciences GmbH Company Details
  • 11.7.2 Arsanis Biosciences GmbH Business Overview
  • 11.7.3 Arsanis Biosciences GmbH Methicillin-Susceptible Staphylococcus Aureus Introduction
  • 11.7.4 Arsanis Biosciences GmbH Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
  • 11.7.5 Arsanis Biosciences GmbH Recent Development
• 11.8 Volcano Corporation
  • 11.8.1 Volcano Corporation Company Details
  • 11.8.2 Volcano Corporation Business Overview
  • 11.8.3 Volcano Corporation Methicillin-Susceptible Staphylococcus Aureus Introduction
  • 11.8.4 Volcano Corporation Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
  • 11.8.5 Volcano Corporation Recent Development
• 11.9 Abbott Laboratories
  • 11.9.1 Abbott Laboratories Company Details
  • 11.9.2 Abbott Laboratories Business Overview
  • 11.9.3 Abbott Laboratories Methicillin-Susceptible Staphylococcus Aureus Introduction
  • 11.9.4 Abbott Laboratories Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
  • 11.9.5 Abbott Laboratories Recent Development
• 11.10 AngioScore Inc.
  • 11.10.1 AngioScore Inc. Company Details
  • 11.10.2 AngioScore Inc. Business Overview
  • 11.10.3 AngioScore Inc. Methicillin-Susceptible Staphylococcus Aureus Introduction
  • 11.10.4 AngioScore Inc. Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
  • 11.10.5 AngioScore Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer